HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MyoVive Heart Drink Available In New York GNC Stores; Expansion Planned

This article was originally published in The Tan Sheet

Executive Summary

A series of clinical trials are being sponsored by Royal Numico's new Nutricia Supplements division to substantiate the cardiac benefits of the firm's new dietary supplement beverage MyoVive.

You may also be interested in...



Functional Beverages Stimulate Natural Products Market Growth - Analysts

The natural products market, fueled by nutritionally fortified foods such as functional beverages, meal replacement bars and soy products, will continue to demonstrate strong annual growth in the mid-teens over the next several years, analysts predict.

Numico Supplement Sales Up Over 1300% Due To GNC, Rexall Acquisitions

General Nutrition Companies' U.S. same-store sales increased 9.3% in the first half of 2000, according to data recently made available by parent company Royal Numico. Same-store sales for GNC outlets overseas rose 13.2% compared to the first half of 1999, Numico reported.

GNC To Gain Broad R&D Pipeline From New Owner Royal Numico

The acquisition of General Nutrition Companies by the Dutch conglomerate Royal Numico will give the Pittsburgh-based supplement retailer an extensive R&D foundation on which to develop original nutritional products. The agreement was announced July 5.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133429

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel